BACK TO TOP
KSE100
181,629.36
-4626.19
(-2.48%)
KSE100PR
55,380.71
-1410.57
(-2.48%)
ALLSHR
109,942.32
-2557.43
(-2.27%)
KSE30
54,279.47
-1392.96
(-2.50%)
KMI30
256,369.76
-6638.08
(-2.52%)
BKTI
51,526.21
-1323.13
(-2.50%)
OGTI
36,774.58
-993.95
(-2.63%)
KMIALLSHR
70,626.90
-1639.91
(-2.27%)
PSXDIV20
83,853.36
-2174.03
(-2.53%)
UPP9
64,396.95
-1683.56
(-2.55%)
NITPGI
48,331.72
-1269.04
(-2.56%)
NBPPGI
52,268.38
-1388.88
(-2.59%)
MZNPI
31,751.90
-808.52
(-2.48%)
JSMFI
42,484.95
-1964.74
(-4.42%)
ACI
24,133.66
-780.58
(-3.13%)
JSGBKTI
77,243.90
-2172.67
(-2.74%)
HBLTTI
18,683.62
06-07-2026
5.21
(0.03%)
MII30
23,369.74
-604.82
(-2.52%)
Ferozsons Laboratories Limited
PHARMACEUTICALS
Rs.397.58
-18.33
(-4.41%)
1D
1M
6M
YTD
1Y
3Y
5Y
^ As of Wed, Jul 8, 2026 3:49 PM
REG
DFC
CSF
ODL
Open
415.00
High
415.00
Low
395.30
Volume
15,629
CIRCUIT BREAKER
374.32 — 457.50
DAY RANGE
395.30 — 415.00
52-WEEK RANGE ^
293.01 — 475.00
Ask Price
0.00
Ask Volume
0
Bid Price
0.00
Bid Volume
0
LDCP
415.91
VAR
19.50
HAIRCUT
22.50
P/E Ratio (TTM) **
26.94
1-Year Change * ^
2.46%
YTD Change * ^
5.81%

No record found

No record found

No record found

Market data powered by capitalstake.com. Provided by PSX. ** Based on unconsolidated financials
  * Returns not adjusted for payouts
  ^The historical stock prices have been adjusted to reflect stock splits to ensure comparability over time.

Company Profile

BUSINESS DESCRIPTION

Ferozsons Laboratories Limited was incorporated as a private limited company on 28 January 1954 and was converted into a public limited company on 08 September 1960. The Company is primarily engaged in the imports, manufacture and sale of pharmaceutical products and medical devices.

KEY PEOPLE
Osman Khalid WaheedCEO
Syed Ghausuddin SaifCompany Secretary
ADDRESS

Ferozsons Laboratories Limited 197-A, The Mall Rawalpindi, Pakistan.

WEBSITE

www.ferozsons-labs.com

REGISTRAR

CorpTec Associates (Pvt.) Limited, 503-E, Johar Town, Lahore

AUDITOR

KPMG Taseer Hadi & Co. Chartered Accountants

Fiscal Year End

June

Equity Profile

Market Cap (000's)
17,282,425.30
Shares
43,469,051
Free Float
15,214,168
Free Float
35.00%

Announcements

Financial Results
Board Meetings
Others
DateTitleDocument
Apr 30, 2026Transmission of Quarterly Report for the Period Ended 31-03-2026 View   PDF
Apr 29, 2026Financial Results for the Quarter Ended 31-03-2026 View   PDF
Feb 27, 2026Transmission of Quarterly Financial Statements for the Period Ended 31-12-2025 View   PDF
Feb 26, 2026Financial Results for the Quarter Ended 31-12-2025 View   PDF
Oct 30, 2025Transmission of Quarterly Financial Statements for the Period Ended 30-09-2025 View   PDF
DateTitleDocument
Jul 7, 2026Board Meeting Other Than Financial Results View   
Jun 12, 2026Notice of Extraordinary General Meeting View   PDF
Jun 11, 2026Notice of Extraordinary General Meeting prior to publication View   PDF
Apr 22, 2026Board Meeting View   
Feb 19, 2026Board Meeting View   
DateTitleDocument
Jul 3, 2026Certified True Copy of Resolution passed by the Shareholders in EOGM of the Company held on July 03, 2026 View   PDF
Jun 24, 2026Election of Directors View   PDF
Jun 19, 2026Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations View   
Jun 19, 2026Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations View   
Jun 2, 2026Intimation of Passing Away of Mrs. Akhter Khalid Waheed, Chairperson and Director View   PDF

Financials

All numbers in thousands (000's) except EPS

Annual
Quarterly
2025202420232022
Sales13,857,96712,711,7149,893,3917,806,414
Profit after Taxation528,243400,054189,042514,149
EPS12.159.204.3511.83
Q3 2026Q2 2026Q1 2026Q3 2025
Sales3,659,6864,405,7813,883,2523,778,689
Profit after Taxation150,250171,195182,420138,117
EPS3.463.934.203.18
Data powered by Capital Stake. To provide comparable data, information might have been standardized. The data presented may therefore differ from issuer's annual report and 'as reported' data should be obtained directly from the source issuer. See the Capital Stake Terms of Use.

Ratios

2025202420232022
Gross Profit Margin (%)41.2738.8838.6345.06
Net Profit Margin (%)3.813.151.916.59
EPS Growth (%)32.07111.49(63.23)(40.91)
PEG1.000.24(0.50)(0.56)

Payouts

Financial Reports